1 domain / 3 areas / 4 specializations
MAC Clinical Research
Data updated
UK research-site network with psychedelic testing suites, early-phase infrastructure, controlled-drug capability, and participant recruitment for depression, PTSD, addiction, and related conditions.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Trial Infrastructure Snapshot
Site Networks & SMOsService Model
Hybrid
Service Coverage
1 country
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
5
Lifecycle Coverage
Service Coverage Countries
Phase Coverage
Capabilities
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 5 sources.
Search Finding
Purpose-built psychedelic testing suites, early-phase unit, controlled-substance manufacturing/distribution, and patient recruitment for relevant psychiatric/addiction populations.
Service Notes
Strong site-network and specialized-services fit. Use regional catchments around verified research sites only.
Linked Stakeholders
No linked stakeholders yet.
Linked Trials
A Study of Oral Ibogaine in Opioid Withdrawal
Completed
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
Completed
Safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of intravenous dosing of SPL026 drug product (N, N-dimethyltryptamine fumarate; DMT Fumarate [A Serotonergic Psychedelic]) alone or in combination with selective serotonin reuptake inhibitors in patients with major depressive disorder
Completed
SPL026 With or Without SSRIs in Participants With MDD
Completed
ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression
Active not recruiting
Safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and effects of intravenous (IV) and intramuscular (IM) dosing of SPL028 (deuterated DMT fumarate [a serotonergic psychedelic]) in healthy volunteers and participants with major depressive disorder (MDD)
Completed
SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Completed
A study carried out on healthy volunteers to understand how COMP360 can be taken in a safe and well-tolerated way
Completed
Source Evidence
MAC Clinical Research — Psychedelics
https://www.macplc.com/psychedelics/
atai / DemeRx — Ibogaine Study Dosing at MAC Unit
https://ir.atai.com/news-releases/news-release-details/demerx-doses-first-subject-phase-12a-study-dmx-1002-ibogaine
MAC Research for You - Clinic Locations
https://researchforyou.co.uk/clinical-trial-centre-locations/
MAC Clinical Research - Locations
https://www.macplc.com/locations/
MAC psychedelic testing suites
https://www.macplc.com/psychedelic-testing-suites/
Quick Facts
- Type
- Other
- HQ
- Greater Manchester clinical research centre - Citylabs, Nelson Street, Manchester M13 9NQ, United Kingdom
- Website
- Visit